WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Contineum Therapeutics earnings were N/A for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CTNM earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$10.3M, up 14% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CTNM reported annual earnings of $3.1M, with -113% growth.

CTNM earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

CTNM Return on Equity

Insufficient data to display

CTNM Return on Assets

Insufficient data to display

Be the first to know when CTNM announces earnings.

CTNM Return on Capital Employed

Current Company
0%
Current Industry
14.3%

CTNM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CTNMN/AN/AN/AN/A
SAGE-$336.28M-$337.59MN/A-$5.57
ZBION/AN/AN/AN/A
VYGR$20.12M$25.88M-10.39%$0.69
XOMA-$20.03M-$34.07MN/A-$3.44
View Top Biotech Stocks

Contineum Therapeutics Earnings Reports & History FAQ

What were Contineum Therapeutics's earnings last quarter?

Contineum Therapeutics (NASDAQ: CTNM) reported Q3 2024 earnings per share (EPS) of -$0.40, up 85.13% year over year. Total CTNM earnings for the quarter were -$10.27 million. In the same quarter last year, Contineum Therapeutics's earnings per share (EPS) was -$2.69.

If you're new to stock investing, here's how to buy Contineum Therapeutics stock.

Is Contineum Therapeutics profitable or losing money?

As of the last Contineum Therapeutics earnings report, Contineum Therapeutics is currently losing money. Contineum Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was N/A, a N/A decrease year over year.

What was CTNM's earnings growth in the past year?

As of Contineum Therapeutics's earnings date in Q4 2024, Contineum Therapeutics's earnings has grown year over year. CTNM earnings in the past year totalled N/A.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.